Brief: Jack Nathan Medical Corp. Announces CEO Transition And Strategic Investor Alignment
23/01/2026 22:57
Jan 23 (Reuters) - Jack Nathan Medical Corp JNH.V: JACK NATHAN MEDICAL CORP. ANNOUNCES CEO TRANSITION AND STRATEGIC INVESTOR ALIGNMENT JACK NATHAN MEDICAL CORP - MIKE MARCHELLETTA STEPS DOWN AS CEO AND VICE-CHAIRMAN JACK NATHAN MEDICAL CORP - MICHAEL DI CESARE APPOINTED INTERIM CEO AND VICE-CHAIRMAN Source text: ID:nBw8cpvLwa Further company coverage: JNH.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jack Nathan Medical
See all newsBrief: Jack Nathan Medical Corp. Announces CEO Transition And Strategic Investor Alignment
Brief: Jack Nathan Health Announces Its Q1 Fiscal 2026 Financial Results
Brief: Jack Nathan Mexico Update
Brief: Jack Nathan Medical To Evaluate M&A Options For Mexico Unit
Brief: Jack Nathan Health Announces Its Q3 Fiscal 2025 Financial Results